D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 42 Citations 6,455 170 World Ranking 4238 National Ranking 254

Overview

What is he best known for?

The fields of study he is best known for:

  • Bacteria
  • Antibiotics
  • Internal medicine

Xavier Bertrand mainly investigates Microbiology, Pseudomonas aeruginosa, Intensive care, Antibiotic resistance and Antimicrobial. The various areas that Xavier Bertrand examines in his Microbiology study include Pulsed-field gel electrophoresis, Gene, Escherichia coli, Multilocus sequence typing and Ceftazidime. Many of his research projects under Pseudomonas aeruginosa are closely connected to Effluent with Effluent, tying the diverse disciplines of science together.

Xavier Bertrand combines subjects such as Colonisation, Colonization, Emergency medicine, Intensive care unit and Pediatrics with his study of Intensive care. Xavier Bertrand interconnects Internal medicine and Antibiotics in the investigation of issues within Antimicrobial. His research in Internal medicine intersects with topics in Surgery and Intensive care medicine.

His most cited work include:

  • Escherichia coli ST131, an Intriguing Clonal Group (428 citations)
  • Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. (157 citations)
  • What happens in hospitals does not stay in hospitals: antibiotic-resistant bacteria in hospital wastewater systems. (120 citations)

What are the main themes of his work throughout his whole career to date?

Xavier Bertrand focuses on Microbiology, Pseudomonas aeruginosa, Antibiotics, Internal medicine and Staphylococcus aureus. His study in Microbiology is interdisciplinary in nature, drawing from both Multilocus sequence typing, Pulsed-field gel electrophoresis and Escherichia coli. His research investigates the link between Pseudomonas aeruginosa and topics such as Intensive care that cross with problems in Intensive care unit.

His Antibiotics research incorporates themes from Medical prescription, Antimicrobial and Vancomycin. His work on Incidence, Confidence interval and Prospective cohort study as part of his general Internal medicine study is frequently connected to Carriage, thereby bridging the divide between different branches of science. His studies examine the connections between Antibiotic resistance and genetics, as well as such issues in Ceftazidime, with regards to Cefotaxime.

He most often published in these fields:

  • Microbiology (48.92%)
  • Pseudomonas aeruginosa (23.38%)
  • Antibiotics (21.65%)

What were the highlights of his more recent work (between 2018-2021)?

  • Microbiology (48.92%)
  • Internal medicine (17.32%)
  • Pseudomonas aeruginosa (23.38%)

In recent papers he was focusing on the following fields of study:

Xavier Bertrand mostly deals with Microbiology, Internal medicine, Pseudomonas aeruginosa, Antibiotic resistance and Escherichia coli. His studies deal with areas such as Methicillin Susceptible Staphylococcus Aureus, Endocarditis, Proteus mirabilis, Enterobacteriaceae and Multilocus sequence typing as well as Microbiology. His Intensive care unit, Incidence, Multivariate analysis and Confidence interval study, which is part of a larger body of work in Internal medicine, is frequently linked to Carriage, bridging the gap between disciplines.

His work carried out in the field of Pseudomonas aeruginosa brings together such families of science as Pathogen, Typing, Genomic island and Pulsed-field gel electrophoresis. His Antibiotic resistance research is under the purview of Antibiotics. His biological study spans a wide range of topics, including Drug resistance, Emergency medicine and Environmental health.

Between 2018 and 2021, his most popular works were:

  • A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance (24 citations)
  • Fourier-Transform InfraRed Spectroscopy Can Quickly Type Gram-Negative Bacilli Responsible for Hospital Outbreaks. (17 citations)
  • Contamination of a hospital plumbing system by persister cells of a copper-tolerant high-risk clone of Pseudomonas aeruginosa (12 citations)

In his most recent research, the most cited papers focused on:

  • Bacteria
  • Antibiotics
  • Internal medicine

Microbiology, Pseudomonas aeruginosa, Antibiotic resistance, Klebsiella pneumoniae and Multilocus sequence typing are his primary areas of study. His research on Microbiology focuses in particular on Typing. His work on Acinetobacter baumannii as part of general Pseudomonas aeruginosa research is frequently linked to Multidrug tolerance, bridging the gap between disciplines.

Antibiotic resistance is a subfield of Antibiotics that Xavier Bertrand studies. His Klebsiella pneumoniae research is multidisciplinary, incorporating perspectives in Contamination, Ecosystem and Bacteria. His studies in Multilocus sequence typing integrate themes in fields like Multiple drug resistance and Pulsed-field gel electrophoresis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Escherichia coli ST131, an Intriguing Clonal Group

Marie-Hélène Nicolas-Chanoine;Xavier Bertrand;Jean-Yves Madec.
Clinical Microbiology Reviews (2014)

694 Citations

Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units.

X Bertrand;M Thouverez;D Talon;A Boillot.
Intensive Care Medicine (2001)

233 Citations

What happens in hospitals does not stay in hospitals: antibiotic-resistant bacteria in hospital wastewater systems.

D Hocquet;Allison Muller;X Bertrand.
Journal of Hospital Infection (2016)

223 Citations

10-Fold increase (2006–11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre

Marie Hélène Nicolas-chanoine;Marie Hélène Nicolas-chanoine;Coraline Gruson;Suzanne Bialek-Davenet;Suzanne Bialek-Davenet;Xavier Bertrand.
Journal of Antimicrobial Chemotherapy (2013)

195 Citations

The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: A multicentre retrospective cohort study

Andréw James Stewardson;Arthur Allignol;Jan Beyersmann;Nicholas Graves.
Eurosurveillance (2016)

187 Citations

Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009

Peter Zarb;Brice Amadeo;Arno Muller;Nico Drapier.
Journal of Antimicrobial Chemotherapy (2011)

181 Citations

Control of the duration of urinary catheterization: impact on catheter-associated urinary tract infection

J. Crouzet;X. Bertrand;A.G. Venier;M. Badoz.
Journal of Hospital Infection (2007)

159 Citations

Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum β-Lactamase–Producing Escherichia coli Into the Environment

Caroline Bréchet;Julie Plantin;Marlène Sauget;Michelle Thouverez.
Clinical Infectious Diseases (2014)

153 Citations

Can MALDI-TOF Mass Spectrometry Reasonably Type Bacteria?

Marlène Sauget;Benoît Valot;Xavier Bertrand;Didier Hocquet.
Trends in Microbiology (2017)

148 Citations

Relationship between Spread of Methicillin-Resistant Staphylococcus aureus and Antimicrobial Use in a French University Hospital

Arno A. Muller;Frédéric Mauny;Maud Bertin;Christian Cornette.
Clinical Infectious Diseases (2003)

143 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Xavier Bertrand

James R. Johnson

James R. Johnson

University of Minnesota

Publications: 45

Stéphan Juergen Harbarth

Stéphan Juergen Harbarth

University of Geneva

Publications: 39

Antonio Oliver

Antonio Oliver

Instituto de Salud Carlos III

Publications: 34

Patrick Plésiat

Patrick Plésiat

University of Franche-Comté

Publications: 30

Herman Goossens

Herman Goossens

University of Antwerp

Publications: 29

Carmen Torres

Carmen Torres

University of La Rioja

Publications: 28

Brian D. Johnston

Brian D. Johnston

University of Minnesota

Publications: 24

Jan Kluytmans

Jan Kluytmans

Utrecht University

Publications: 23

Erick Denamur

Erick Denamur

Université Paris Cité

Publications: 22

Paul Thuras

Paul Thuras

University of Minnesota

Publications: 22

Olivier Clermont

Olivier Clermont

Université Paris Cité

Publications: 21

Petra Gastmeier

Petra Gastmeier

Charité - University Medicine Berlin

Publications: 20

Rafael Cantón

Rafael Cantón

Instituto Ramón y Cajal de Investigación Sanitaria

Publications: 20

Marc J. M. Bonten

Marc J. M. Bonten

Utrecht University

Publications: 20

Álvaro Pascual

Álvaro Pascual

University of Seville

Publications: 18

François Vandenesch

François Vandenesch

Claude Bernard University Lyon 1

Publications: 17

Trending Scientists

David Grove

David Grove

IBM (United States)

Marco Locatelli

Marco Locatelli

University of Parma

R. Venkata Rao

R. Venkata Rao

Sardar Vallabhbhai National Institute of Technology Surat

Tijana Rajh

Tijana Rajh

Argonne National Laboratory

Vinod K. Aswal

Vinod K. Aswal

Bhabha Atomic Research Centre

Clare McCabe

Clare McCabe

Vanderbilt University

Philippe Collas

Philippe Collas

University of Oslo

Troy Stevens

Troy Stevens

University of South Alabama

Andrzej Ciereszko

Andrzej Ciereszko

Polish Academy of Sciences

Matthias Fischer

Matthias Fischer

University of Cologne

Volker Lohmann

Volker Lohmann

Heidelberg University

Dennis K. Bird

Dennis K. Bird

Stanford University

Ximing Cai

Ximing Cai

University of Illinois at Urbana-Champaign

Patrick Lussier

Patrick Lussier

Université Laval

Satoshi Ogawa

Satoshi Ogawa

Keio University

Hirotsugu Ueshima

Hirotsugu Ueshima

Shiga University of Medical Science

Something went wrong. Please try again later.